Crinetics Pharmaceuticals

CRNXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$8.918 B

$84.08 +0.19%

Close of 7 Aug 2026

Revenue

$1.04M

#3497 by revenue

Earnings

-$465.3M

Loss-making

Shares outstanding

106,065,229

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#40Ionis PharmaceuticalsIONS$9.40B
#41Spyre TherapeuticsSYRE$9.25B
#42Crinetics PharmaceuticalsCRNX$8.92B
#43AlkermesALKS$8.25B
#44LiquidiaLQDA$8.02B

Where these numbers come from

Share counts and financials for Crinetics Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.